| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/13/2001 | EP1105159A2 Lt and ct in parenteral immunization methods against helicobacter infection |
| 06/13/2001 | EP1105157A1 Protein delivery system using human papillomavirus virus-like particles |
| 06/13/2001 | EP1105155A1 Vaccine comprising cytokine-induced heat shock proteins (hsp) |
| 06/13/2001 | EP1105154A1 Bacterial superantigen vaccines |
| 06/13/2001 | EP1105153A1 Multivalent vaccine for (clostridium botulinum) neurotoxin |
| 06/13/2001 | EP1105150A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 06/13/2001 | EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body |
| 06/13/2001 | EP1105142A2 Blood-brain barrier therapeutics |
| 06/13/2001 | EP1105100A1 Alginate capsules for use in the treatment of brain tumour |
| 06/13/2001 | EP0725798B1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridoma |
| 06/13/2001 | EP0656010B1 Use of peptides causing a immune response for the preparation of medicaments to induce the suppression of the immune reaction. |
| 06/13/2001 | CN1299414A Compound and method for therapy and diagnosis of lung cancer |
| 06/13/2001 | CN1299410A CD 19XCD2 specific polypeptides and uses thereof |
| 06/13/2001 | CN1299288A Combined vaccine compositions |
| 06/13/2001 | CN1299287A Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 06/13/2001 | CN1299272A Method and device for modulating the immune response |
| 06/12/2001 | USRE37224 Immunization of seals |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245890 A purified red blood cell antigen which binds to zenoreactive human antibodies; therapy for xenograft rejection |
| 06/12/2001 | US6245885 Bax-mediated apoptosis modulating reagents and methods |
| 06/12/2001 | US6245883 An isolated lectin derived peptide; therapy, antiinflammatory agent, suppressing cell adhesion, antimetastasis agents |
| 06/12/2001 | US6245752 Antigenic carbohydrate determinant; anticarcinogenic agents |
| 06/12/2001 | US6245568 Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
| 06/12/2001 | US6245560 Vector with multiple target response elements affecting gene expression |
| 06/12/2001 | US6245549 Culturing virus from paramyxoviridae family in media free of exogenous serum proteins, isolating virus, solubilizing envelope glycoproteins; using affinity chromotography to isolate/purify immunogenic envelope glycoproteins; infants |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245532 Baculovirus signal peptide; for the development of therapy for prevention of viral disease |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245359 Active agent transport systems |
| 06/12/2001 | US6245338 OMP26 antigen from Haemophilus influenzae |
| 06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
| 06/12/2001 | US6245335 Choline binding proteins for anti-pneumococcal vaccines |
| 06/12/2001 | US6245334 Polypeptide containing lecithin |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | US6245332 Modulation of systemic memory T cell trafficking |
| 06/12/2001 | US6245329 Method of inducing calcium flux in cells using mammalian thymokine protein |
| 06/12/2001 | CA2086097C Adjuvants and vaccines |
| 06/12/2001 | CA2060384C A pharmaceutical composition containing an antibody recognizing the cdw52 antigen |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA1341251C Pox virus vectors |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/08/2001 | CA2290722A1 Consensus peptide presenting entities |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040469A2 Tick antigens and compositions and methods comprising them |
| 06/07/2001 | WO2001040465A2 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040449A2 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof |
| 06/07/2001 | WO2001040446A1 Pour-on formulations |
| 06/07/2001 | WO2001040439A2 CLONING AND EXPRESSION OF A DNA SEQUENCE ENCODING A 41 kDa CRYPTOSPORIDIUM PARVUM OOCYST WALL PROTEIN |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040290A1 Immunogen, antivenom and vaccine against the venom of the black widow spider |
| 06/07/2001 | WO2001040282A1 Compositions isolated from m. vaccae and their use in the modulation of immune responses |
| 06/07/2001 | WO2001040281A2 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
| 06/07/2001 | WO2001040280A2 Composition and method for treating a microbial infection |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040274A2 Inhibition of hrsv membrane fusion |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040270A2 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies |
| 06/07/2001 | WO2001040269A2 Compositions and methods for therapy and diagnosis of breast cancer |
| 06/07/2001 | WO2001040266A2 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 06/07/2001 | WO2001040264A2 Peptide antigens |
| 06/07/2001 | WO2001040248A1 Cryptosporidium sporozoite antigens |
| 06/07/2001 | WO2001040240A2 Mono- and disaccharide derivatives |
| 06/07/2001 | WO2001039803A2 Interleukin-1 muteins useful as vaccine adjuvants |
| 06/07/2001 | WO2001039802A1 Chimeric flavivirus vaccines |
| 06/07/2001 | WO2001039801A2 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 06/07/2001 | WO2001039800A2 Controlled delivery of antigens |
| 06/07/2001 | WO2001039799A2 Passive desensitization |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039797A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/07/2001 | WO2001039796A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039778A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 06/07/2001 | WO2001025213A3 Pyrrolo imidazole derivatives and their use as medicaments |
| 06/07/2001 | WO2001013946A3 Method for isolating and purifying grass pollen allergens |
| 06/07/2001 | WO2001011971B1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2000078960A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | WO1999052548A9 Conjugate vaccines for the prevention of dental caries |
| 06/07/2001 | WO1999002187A3 Decreased fat absorption with an anti-lipase antibody |
| 06/07/2001 | DE19958388A1 Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten Triazinone compounds for the treatment of diseases caused by infestation with parasitic protozoa |
| 06/07/2001 | DE19957904A1 Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung Insect venom allergens with reduced IgE-reactivity, and methods for their preparation |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2397731A1 Immunogen antivenom and vaccine against the venom of the black widow sp ider |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2393325A1 Infectious clones |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392933A1 Cryptosporidium sporozoite antigens |
| 06/07/2001 | CA2392906A1 Pseudomonas aeruginosa antigens |
| 06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |